Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04636905 · ClinicalTrials.gov registry record
Evaluation of Survivorship Wellness Group Program for Patients Treated at University of California, San Francisco (UCSF)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 53
- Enrollment target
NCT04636905: Completed study, sponsored by University of California, San Francisco.
NCT04636905 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04636905 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
Interdisciplinary psychological interventions targeting survivorship are not only understudied but face several implementation challenges. For this project, the study team is proposing to analyze these data to report on preliminary pilot outcomes, as well as acceptability and feasibility of the implementation of the Survivorship Wellness Group Program, an interdisciplinary wellness and health-behavior change program for survivors of cancer, who have completed treatment at University of California, San Francisco and are currently without evidence of active disease.
Primary Outcome
The PROMIS Depression Short form consists of 4 items addressing patient depression with item response scores ranging from 1 (never) to 5 (Always). Raw scores are converted to scaled T-scores with higher scores indicating a greater level of depression.
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-05-26 |
| Est. Completion | 2024-01-30 |
What the finished NCT04636905 record still lists
NCT04636905 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT04636905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04636905 about?
NCT04636905 is a clinical study titled "Evaluation of Survivorship Wellness Group Program for Patients Treated at University of California, San Francisco (UCSF)". Interdisciplinary psychological interventions targeting survivorship are not only understudied but face several implementation challenges. For this project, the study team is proposing to analyze these data to report on preliminary pilot outcomes, as well as acceptability and feasibility of the impl...
What is the current status of trial NCT04636905?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2020-05-26. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT04636905?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT04636905?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI